Investigation of the mechanisms underlying the beneficial metabolic effects of multi-agonist therapies, conducted in PWA mice, as a genuine model for the metabolic alterations of PCOS 36 , revealed a predominant action in terms of suppression of food intake, with negligible effects in terms of energy expenditure, thermogenic function or locomotor activity
No adverse events were mentioned in either of the two groups
Binding to the GLP-1 receptor promotes insulin secretion in a glucose-dependent manner, slows gastric emptying, and reduces appetite through central nervous system signaling, aiding in glycemic control and weight loss
Healthy fats support hormone production and reduce inflammation
Yang L, Venneti S, Nagrath D
Its especially suited for patients seeking structural cognitive improvements rather than temporary stimulation